NextPharma News

NextPharma completes its acquisition of a leading European chewable tabletspharmaceutical manufacturing site in Asker, Norway

Meet the NextPharma Team at CPHI: 24 – 26 October 2023, Barcelona

Meet the NextPharma Team at AAPS PharmSci: 22 – 25 October 2023, Orlando

Meet the NextPharma Team at Contract Pharma 2023: 21 - 22 September 2023, New Jersey

Meet the NextPharma Team at the Bio International Convention 2023: 05 - 08 June 2023, Boston

Meet the NextPharma Team at BioMed Israel 2023: 16 - 18 May 2023, TelAviv

Meet the NextPharma Team at Vitafoods: 9 -11 May 2023, Geneva

Meet the NextPharma Team at CPhI North America: 25 - 27 April 2023, Philadelphia

Drug manufacturer from Goettingen wants to triple the number of apprentices / 450 employees in Goettingen

(Published in Göttinger Tageblatt)

NextPharma to acquire Takeda's Manufacturing Site in Asker, Norway

Meet the NextPharma Team at Connect in Pharma: 14 – 15 September 2022, Geneva

We look forward to meeting you at the World Clinical Trial Supply Forum, 5 – 6 October 2022, Munich

Meet the NextPharma Team at the AAPS Pharm Sci Annual Meeting, 16 – 19 October 2022, Boston

We look forward to meeting you at CPhI Worldwide, 1 – 3 November 2022, Frankfurt

Meet the NextPharma team at BioMed Israel, May 10-12 2022, Tel Aviv, Israel, booth #45,

Meet the NextPharma Team at Formulation & Delivery UK, May 05-06 2022, London, UK, booth #2

Join us at CPhI North America, 17-19 May 2022, Philadelphia, USA, Booth #828

Join us at PBP World Meeting, March 28th – 31st 2022, Rotterdam Netherlands, Booth #11

Join us at DCAT Week New York, March 21st – 24th 2022, Lotte NY Palace, Suite #4817

NextPharma announces the completion of the acquisition of Lonza's Ploermel (FR) and Edinburgh (UK) sites.

Lonza and NextPharma announced an agreement for the potential sale of Lonza's Ploermel (FR) and Edinburgh (UK) sites.

NextPharma invests €15 million to increase oral solid dosage form manufacturing and packaging capacity at its Göttingen site